Membrane Binding, Structure, and Localization of Cecropin-Mellitin Hybrid Peptides: A Site-Directed Spin-Labeling Study  by Bhargava, Kalpana & Feix, Jimmy B.
Biophysical Journal Volume 86 January 2004 329–336 329
Membrane Binding, Structure, and Localization of Cecropin-Mellitin
Hybrid Peptides: A Site-Directed Spin-Labeling Study
Kalpana Bhargava and Jimmy B. Feix
Department of Biophysics, Medical College of Wisconsin, Milwaukee, Wisconsin
ABSTRACT The interaction of antimicrobial peptides with membranes is a key factor in determining their biological activity.
In this study we have synthesized a series of minimized cecropin-mellitin hybrid peptides each containing a single cysteine
residue, modiﬁed the cysteine with the sulfhydryl-speciﬁc methanethiosulfonate spin-label, and used electron paramagnetic
resonance spectroscopy to measure membrane-binding afﬁnities and determine the orientation and localization of peptides
bound to membranes that mimic the bacterial cytoplasmic membrane. All of the peptides were unstructured in aqueous solution
but underwent a signiﬁcant conformational change upon membrane binding that diminished the rotational mobility of the
attached spin-label. Apparent partition coefﬁcients were similar for ﬁve of the six constructs examined, indicating that location of
the spin-label had little effect on peptide binding as long as the attachment site was in the relatively hydrophobic C-terminal
domain. Depth measurements based on accessibility of the spin-labeled sites to oxygen and nickel ethylenediaminediacetate
indicated that at high lipid/peptide ratios these peptides form a single a-helix, with the helical axis aligned parallel to the bilayer
surface and immersed ;5 A˚ below the membrane-aqueous interface. Such a localization would provide exposure of charged/
polar residues on the hydrophilic face of the amphipathic helix to the aqueous phase, and allow the nonpolar residues along the
opposite face of the helix to remain immersed in the hydrophobic phase of the bilayer. These results are discussed with respect
to the mechanism of membrane disruption by antimicrobial peptides.
INTRODUCTION
Over the past two decades a large number of antimicrobial
peptides have been identiﬁed from a wide range of both
vertebrate and invertebrate species (Boman, 1995; Hancock
and Scott, 2000; Zasloff, 2002). They include linear peptides
such as the magainins (Zasloff, 1987), indolicidin (Selsted
et al., 1992), and cecropins (Hultmark et al., 1980), as well as
cyclic peptides that contain one or more disulﬁde bonds such
as the defensins (Selsted et al., 1985; Lehrer et al., 1991).
These peptides form the ‘‘innate immunity’’ arm of host
defense, providing broad-spectrum protection against in-
vading pathogens before activation of classic antibody- and
cell-mediated immunity. Although they are of evolutionarily
ancient lineage, the occurrence of bacterial resistance to
antimicrobial peptides is exceedingly rare (Hancock and
Scott, 2000; Zasloff, 2002). This is due to the fact that, in
contrast to the vast majority of antibiotics in clinical use,
these peptides appear to target general properties of the
microbial membrane (Maloy and Kari, 1995; Hancock and
Scott, 2000; Zasloff, 2002). Consequently, acquired re-
sistance would require an overall restructuring of membrane
composition and/or organization. For this reason, and
because of the ever-increasing prevalence of multiple-drug
resistant pathogens, there has been considerable interest in
the development of these peptides as a new source of
antibiotics (Hancock and Scott, 2000; Zasloff, 2002).
Despite their remarkable diversity, antimicrobial peptides
share two common features: a net positive charge and the
propensity to adopt amphipathic secondary structures in
the presence of membranes (Hancock, 2001; Zasloff, 2002).
One particularly prominent group of antimicrobial peptides
consists of linear peptides that form amphipathic a-helices
(Maloy and Kari, 1995; Dathe and Wieprecht, 1999;
Giangaspero et al., 2001). Included among these are the
cecropins, a family of peptides typically 33–39 amino acids in
length ﬁrst isolated from the silk moth, Hyalophora cecropia
(Hultmark et al., 1980; Steiner et al., 1981). Cecropins display
broad-spectrum antimicrobial activity (Steiner et al., 1981;
Andreu et al., 1985; Fink et al., 1989b) and have a general
structural motif consisting of a basic N-terminal amphi-
pathic helical domain connected to a relatively hydrophobic
C-terminal domain by a ﬂexible hinge (Holak et al., 1988).
In an effort to reduce the size of the cecropins to facilitate
their solid-phase synthesis, Boman, Merriﬁeld, and co-
workers identiﬁed a group of signiﬁcantly shortened hybrids
of cecropin A and the bee venom peptide, mellitin, that
displayed antibacterial activity comparable to the full-length
cecropins and yet lacked the hemolytic properties associated
with mellitin (Boman et al., 1989; Fink et al., 1989a; Wade
et al., 1992; Andreu et al., 1992). A hybrid consisting of the
ﬁrst seven residues of cecropin A and residues two through
nine of mellitin, C(1–7)M(2–9) (which we designate CM15),
was identiﬁed as the minimal sequence with strong anti-
microbial efﬁcacy (Andreu et al., 1992). CM15, like the
native cecropins, has a highly basic N-terminal domain and
a relatively hydrophobic C-terminal domain (Table 1). As
with cecropin A (Wade et al., 1990), the all-D enantiomer of
CM15 retains biological activity against a broad panel of
bacterial species (Merriﬁeld et al., 1995), indicating that
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interaction with cellular targets occurs in a nonstereospeciﬁc
manner.
Despite extensive study, the precise mechanisms of
peptide-membrane interaction and cell killing have not been
ﬁrmly established for many antimicrobial peptides. It has
been suggested that, after translocation across the outer
membrane or cell wall, disruption of the cytoplasmic mem-
brane is the lethal event leading to bacterial cell death
(Westerhoff et al., 1989; Hancock and Chapple, 1999;
Silvestro et al., 2000; Yang et al., 2000). This may occur
through a detergentlike ‘‘carpet’’ mechanism (Steiner et al.,
1988; Gazit et al., 1995; Shai, 2002), or the formation of
discrete channels that dissipate ion gradients (Christensen
et al., 1988; Kagan et al., 1990; Juvvadi et al., 1996).
Although recent studies have shown that some antimicrobial
peptides interact with intracellular targets (Otvos, Jr. et al.,
2000) and bind DNA (Zhang et al., 1999), these peptides still
must traverse the cell membrane to reach their site of action.
Full-length cecropins have been proposed to act through
both the carpet mechanism (Steiner et al., 1988) and by
formation of ion channels (Christensen et al., 1988; Silvestro
et al., 1997). CM15 has also been shown to form ion
channels in planar bilayers (Juvvadi et al., 1996); however,
there have been no detailed studies on the membrane
interactions of these minimized peptides.
In the present study, we have utilized site-directed spin-
labeling electron paramagnetic resonance (EPR) spectro-
scopy to measure partition coefﬁcients for a series of
spin-labeled, single-cysteine analogs of CM15, and to
examine the structure and localization of CM15 when bound
tomembranes thatmimic the lipid composition of the bacterial
cytoplasmic membrane.We ﬁnd that CM15 is unstructured in
aqueous solution, but upon membrane binding forms an
a-helix that intercalates just below the surface of the aqueous-
membrane interface, aligned parallel to the bilayer surface.
Changes in the free energy of binding for different spin-
labeling sites did not correlate with standard side-chain free
energies, andwere apparently dependent on sequence context.
MATERIALS AND METHODS
Escherichia coli bacterial polar lipids (BPL), POPE (1-palmitoyl-2-oleoy-
lphosphatidylethanolamine), POPG (1-palmitoyl-2-oleoylphosphatidylgly-
cerol), and n-PCSL (n-doxyl-phosphatidylcholine; n ¼ 5, 7, 10, 12)
spin-labels were obtained from Avanti Polar Lipids (Alabaster, AL). The
composition of BPL is PE/PG/cardiolipin (CL) 67:23.2:9.8 (% 3 wt),
corresponding to a molar ratio of ;68:26:6. This is in good agreement with
the composition of E. coli inner membrane lipids (Gennis, 1989). Rink
amide MBHA resin and n-Fmoc L-amino acids were purchased from
Novabiochem (La Jolla, CA). Acetic anhydride, DIC (diisopropylcarbodii-
mide), DCM (dichloromethane), HOBt (1-hydroxybenzotriazole), TIS
(triisopropylsilane), piperidine, and NMP (n-methylpyrrolidinone) were
purchased from Fisher Scientiﬁc (Hampton, NH). NiEDDA (nickel
ethylenediaminediacetate) was synthesized by a protocol kindly provided
by Dr. Christian Altenbach (Jules Stein Eye Institute, UCLA School of
Medicine, Los Angeles, CA). The methanethiosulfonate spin-label, MTSL
(1-oxy-2,2,5,5-tetramethylpyrroline-3-methyl), was obtained from Toronto
Research Chemicals (North York, ON, Canada).
Liposome preparation
Lipids in desired molar ratios were dried down from chloroform stock
solutions under nitrogen gas and further dried at least 1 h under vacuum. The
resulting lipid ﬁlm was hydrated by addition of 20 mMMOPS and 100 mM
KCl (pH 7.0) to give a concentration of ;100 mM phospholipid. Large
unilamellar vesicles (LUVs) were prepared by freeze-thawing this lipid
suspension 53, followed by extrusion through 100-nm polycarbonate
membrane ﬁlters (Osmonics, Minnetonka, MN) using a miniextruder
syringe device (Lipex Biomembranes, Vancouver, BC, Canada). Final lipid
concentration was measured by the method of Stewart (1980).
Peptide synthesis and spin-labeling
Peptides were synthesized on rink amide p-methylbenzhydrylamine resin
with acetylated N-termini and amidated C-termini by solid-phase synthesis
methods using standard n-(9-ﬂuororenyl)methoxycarbonyl (Fmoc) chemis-
try. Coupling of Fmoc amino acids was performed with equal volumes of 0.5
M HOBt and 0.5 M DIC in NMP. The Fmoc-protecting group was removed
with 25% piperidine in NMP, followed by washing 33 each in NMP and
DCM. Amino acid side chains were protected as trityl (Cys) and Boc (Lys
and Trp). N-terminal acetylation was carried out with excess acetic
anhydride in the presence of coupling reagents HOBt and DIC at room
temperature for 4 h. Deprotection and cleavage of peptide from the resin
were carried out using TFA, TIS, and double-distilled water (98:1:1, v/v) for
3 h at room temperature. The peptides were precipitated and washed 33
with cold diethyl ether and dried under vacuum. Crude peptides were
puriﬁed by reverse-phase semipreparative HPLC on a 10-mm, 1.0 3 25-cm
C8 column (Vydac, Hesperia, CA) using a linear gradient of 10 to 80%ACN
(acetonitrile) in water/0.1% TFA over 40 min. Upon elution the peptides
were lyophilized, resuspended in a small volume of ACN:20 mM MOPS,
pH7 (1:1), reacted with a ﬁvefold molar excess of MTSL for 3 h at room
temperature, and then rechromatographed as described above to remove
excess spin-label. Peptide purity was checked by analytical HPLC and
molecular mass veriﬁed by MALDI-TOF mass spectrometry in the Protein-
Nucleic Acid Shared Facility of the Medical College of Wisconsin
(Milwaukee, WI).
Listed in Table 1 are the amino acid sequences of the lead peptide, CM15,
and six analogs, each of which contains a single cysteine residue to serve as
an attachment site for the sulfhydryl-speciﬁc nitroxide spin-label, MTSL.
Nonpolar residues were selected for substitution with cysteine and spin-
labeling inasmuch as the side chain of MTSL is relatively hydrophobic (Yu
et al., 1994). In addition, aromatic residues in the amphipathic N-terminal
domain were left unchanged as they have been shown to be essential for
antibacterial activity in full-length cecropins (Andreu et al., 1985).
EPR measurements of accessibility and
immersion depth
The accessibility of the spin-label to the diffusible relaxation agents O2 and
NiEDDA was determined by continuous-wave power saturation (Altenbach
TABLE 1 Cecropin-mellitin hybrid peptides
Peptide Sequence
CM15 Ac-KWKLFKKIGAVLKVL-NH2
CM15-C4 Ac-KWKCFKKIGAVLKVL-NH2
CM15-C8 Ac-KWKLFKKCGAVLKVL-NH2
CM15-C10 Ac-KWKLFKKIGCVLKVL-NH2
CM15-C11 Ac-KWKLFKKIGACLKVL-NH2
CM15-C12 Ac-KWKLFKKIGAVCKVL-NH2
CM15-C14 Ac-KWKLFKKIGAVLKCL-NH2
Primary sequencesof peptides showingpositionsof the cysteine labeling sites.
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et al., 1989). Spin-labeled peptides were mixed with LUVs to give ﬁnal
concentrations of 40 mM lipid and 0.2 mM peptide in a ﬁnal volume of
5 to 10 ml, and placed into gas-permeable TPX capillaries (Molecular
Specialties, Milwaukee, WI). Samples containing NiEDDA were incubated
at 378C for at least 2 h before analysis to allow equilibration across the
membrane bilayer. No differences were observed between samples
incubated 2 h at 378C and samples allowed to equilibrate at room
temperature overnight. As shown in Fig. 2, at these high lipid/peptide ratios
the spin-labeled peptides were fully membrane-bound. EPR spectra for
power saturation studies were obtained on a Varian E-102 Century series
spectrometer equipped with an X-band two-loop one-gap resonator
(Molecular Specialties, Milwaukee, WI). Values for the saturation parameter
P1/2 were determined for each sample under three conditions: saturated with
N2, saturated with air (20% O2), and under N2 in the presence of 20 mM
NiEDDA. The change in P1/2, DP1/2 is a direct measure of the bimolecular
collision rate between the spin-label and the relaxation agent and, hence, the
accessibility of the spin-label to a given paramagnetic probe (Altenbach
et al., 1989). To account for differences in spin-label mobility and resonator
performance, DP1/2 values are multiplied by the inverse width of the center
line (DH0
1) and normalized according to DH0 and P1/2 for a DPPH
(diphenylpicrylhydrazine) standard giving the accessibility parameter, P
(Farahbakhsh et al., 1992),
P ¼ ½DP1=2=DH0 ½P1=2 ðDPPHÞ=DH0 ðDPPHÞ1: (1)
The concentrations of oxygen and NiEDDA have been shown to vary
along the bilayer normal in inverse fashion, providing the basis of a method
to measure the transmembrane location of a spin-label exposed to the lipid
phase (Altenbach et al., 1994). The depth parameter, F, is deﬁned as
F ¼ ln ½PðO2Þ=PðNiEDDAÞ: (2)
The dependence of F on bilayer depth is calibrated with n-doxyl-
phosphatidylcholine spin-labels (n-PCSL) in the same membrane system
(including unlabeled peptide) that is employed for protein studies
(Altenbach et al., 1994; Klug et al., 1997). Liposomes containing 0.5 mol
% of 5-, 7-, 10-, or 12-PCSL were prepared in BPL and extruded to prepare
LUVs as described above. The parent peptide, CM15 (Table 1), was added
to give a lipid/peptide ratio of 200:1 before analysis. A linear ﬁt to the known
depths of the PCSL standards (Dalton et al., 1987) yielded the relationship of
depth (A˚) ¼ 4.62 F 1 3.89.
EPR measurement of partition coefﬁcients
For peptide-binding assays a constant amount of spin-labeled peptide was
mixed with various concentrations of LUVs to give a ﬁnal sample volume of
40 ml and a ﬁnal peptide concentration of 35 to 50 mM. All stock solutions
and dilutions were made with 20 mM MOPS and 100 mM KCl, pH 7.0.
Peptide-lipid mixtures were incubated at room temperature for 30 min,
loaded into 50-ml glass capillaries, and the EPR spectrum recorded on
a Varian E-102 Century series spectrometer equipped with a TE102 cavity at
a microwave power at 10 mW using a 100-kHz, 1.0-G ﬁeld modulation.
Signal averaging and measurement of signal amplitudes were accomplished
with software written in LabView by Dr. C. Altenbach.
Methodology for quantitating the binding of spin-labeled peptides to
membranes is well-established (Archer et al., 1991; Mchaourab et al., 1994;
Thorgeirsson et al., 1996; Victor and Caﬁso, 2001; reviewed by Feix and
Klug, 1998). Shown in Fig. 1 are EPR spectra for MTSL-labeled CM15-C12
free in solution and in equilibrium with LUVs where;90% of the peptide is
membrane-bound. The fraction of bound peptide, fb, is calculated according
to the relation
fb ¼ ½Að1Þf  Að1Þx=½Að1Þf  Að1Þb; (3)
where A(1)f and A(1)x are the peak-peak amplitudes of the high-ﬁeld
(MI ¼ 1) line for the peptide free in solution and in the given experimental
sample, respectively (Fig. 1). A(1)b. The amplitude of the high-ﬁeld line
when the peptide is fully bound was measured at high lipid/peptide
concentrations, and was typically\3% of A(1)f, thus representing a small
correction. The concentrations of membrane-bound peptide, Cb, and peptide
remaining free in solution, Cf, were calculated from fb and the known total
concentration of peptide. To determine the apparent partition coefﬁcient, Kp,
the molar ratio of bound peptide to lipid, Xb, was plotted against Cf (e.g., see
Fig. 5). For ideal partitioning behavior a plot of Xb against Cf will yield
a straight line of slope, Kp, i.e., Xb ¼ Kp Cf where Kp is in units of M1
(Spuhler et al., 1994; Russell et al., 1996; Han and Tamm, 2000). It was
assumed that the peptides bound only to the outer surface of the LUVs, so
that the accessible lipid concentration was taken to be one-half the total lipid
concentration. It was observed that addition of 50 mM chromium oxalate,
a nonpermeant relaxation agent, to vesicle-peptide suspensions completely
broadened the EPR signal of the spin-labeled peptide. This indicates that
these peptides remain on the exterior of the vesicles, at least in the time
frame (\1 h) of these experiments. Partition coefﬁcients were determined
under conditions where bound peptide was a small fraction of the accessible
membrane lipid, so as to not perturb the membrane surface charge density.
RESULTS
Structure of the membrane-bound peptide
Shown in Fig. 2 are the EPR spectra for a series of MTSL-
labeled single-cysteine analogs of CM15 in aqueous solu-
tion and following the addition of LUVs that mimic the
composition of the bacterial cytoplasmic membrane. In
aqueous solution the spectra all consist of three narrow lines
indicative of rapid rotational motion of the spin-label with
subnanosecond rotational correlation times. This is consis-
tent with what is expected for small, unstructured peptides in
solution. Upon binding of the peptides to membranes their
EPR spectra are all signiﬁcantly broadened, indicating
a decrease in mobility with rotational correlation times in
the range of 3 to 5 ns. Line widths and rotational correlation
times were independent of the concentration of membrane-
bound peptide for lipid/peptide ratios[120:1 (60:1 if one
considers only the outer leaﬂet of the bilayer), and there was
FIGURE 1 EPR spectra of MTSL-labeled CM15-C12 (top) in aqueous
solution and (bottom) in the presence of POPE/POPG (80:20) LUVs with
;90% bound. At bottom, the spectrum of fully-bound peptide (dashed line)
is superimposed. The peak-peak amplitudes A(1)f and A(1)x are used to
calculate the fraction of peptide bound (Eq. 3).
Membrane Binding of Cecropin Peptides 331
Biophysical Journal 86(1) 329–336
no evidence in the spectra of strong spin-spin interaction,
indicating that these peptides are monomeric when bound
at high lipid/peptide ratios. The ability to prepare samples
in which peptides are fully bound and in the monomeric
aggregation state facilitated the mapping of secondary
structure and immersion depth for the membrane-bound
peptides, as described below.
To characterize the structure of the membrane-bound state
of the peptide, we examined the accessibility of the spin-
label side chain to the paramagnetic relaxation agents, O2
and NiEDDA. NiEDDA is a polar, neutral solute that
partitions primarily into the aqueous phase, whereas oxygen
is nonpolar and partitions favorably into membranes with
a gradient of increasing concentration that reaches a maxi-
mum near the center of the bilayer. The inverse concentration
gradients of O2 and NiEDDA provide a basis for determining
the depth of a spin-label in the lipid bilayer (Altenbach et al.,
1994). The EPR accessibility parameters for O2 and
NiEDDA are given in Table 2 and shown as a function of
spin-label position in Fig. 3. Notably, the residue/residue
variation in accessibilities to O2 and NiEDDA are out-
of-phase (Fig. 3), which is a classic indication of interaction
with a lipid bilayer (Feix and Klug, 1998; Hubbell et al.,
1998).
Depth parameters based on differential accessibility to O2
and NiEDDA (Eq. 2) are given in Table 2, and immersion
depths of the spin-label side chain are shown as a function of
labeling position in Fig. 4. For the sites examined in this
study, all of which correspond to nonpolar residues in the
native peptide (Table 1), the spin-label attached at C10 had
the greatest accessibility to NiEDDA, and C12 was the most
deeply buried site (i.e., least accessible to NiEDDA and most
accessible to O2). As seen in Fig. 4, the experimental data
maps very well to a periodicity of 3.6 residues/turn,
consistent with a well-deﬁned a-helix. Furthermore, the
similarity in depths for sites C4, C8, and C12, as well as for
C10 and C14, indicates that the axis of the helix is oriented
FIGURE 2 Room temperature EPR spectra of single-cysteine CM15
analogs labeled with MTSL (left) in aqueous solution, and (right) bound to
LUVs composed of bacterial inner membrane lipids (PE/PG/CL, 68:26:6) at
a lipid/peptide molar ratio of 200:1. Scan widths are 100 G.
TABLE 2 EPR accessibility and depth parameters
Labeling site P(O2)* P(NiEDDA)
y Fz Depth (A˚)z
C4 0.48 6 0.02 0.14 6 0.02 1.23 6 0.20 9.5 6 1.0
C8 0.60 6 0.02 0.10 6 0.03 1.79 6 0.39 12.2 6 1.8
C10 0.42 6 0.02 1.48 6 0.02 1.26 6 0.06 1.9 6 1.0
C11 0.51 6 0.03 0.48 6 0.02 0.06 6 0.10 4.2 6 0.4
C12 0.64 6 0.01 0.10 6 0.02 1.86 6 0.22 12.5 6 0.8
C14 0.45 6 0.02 0.84 6 0.02 0.62 6 0.06 1.0 6 0.4
*Accessibility parameter for air (20% O2).
yAccessibility parameter for 20 mM NiEDDA. Uncertainties in P values
are standard errors based on replicate experiments (n ¼ 2–3 for each site).
zUncertainties in F and depth are calculated from the maximum uncer-
tainties in P values.
FIGURE 3 Accessibility parameters for oxygen, P(O2) (d), and 20 mM
NiEDDA, P(NiEDDA) (), as a function of labeling position. Horizontal
error bars indicate the standard error of the mean from replicate experiments.
Lines between points are shown to emphasize the out-of-phase behavior of
the accessibilities.
FIGURE 4 Immersion depth as a function of labeling position. Depths
relative to the membrane-aqueous interface were calculated from the depth
parameter,F (Eq. 2), and comparison to a series of n-doxylphosphatidylcho-
line spin-labels. Error bars are based on the maximum propagation of the
uncertainties in P values. Positive values indicate sites embedded in the
hydrophobic phase and negative values exposure to the aqueous phase. The
solid line is a sine curve with a periodicity of 3.6.
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parallel to the bilayer surface. Immersion depths varied from
;12 A˚ deep in the membrane to 2 A˚ above the bilayer
surface (Fig. 4). This 14 A˚ span is in good agreement with
the dimensions expected for a helical cylinder aligned par-
allel to the bilayer surface, given that the length of the MTSL
side chain is;6–7 A˚ (Rabenstein and Shin, 1995). This sug-
gests that the central axis of the helix is positioned ;5 A˚
below the aqueous-membrane interface, or at about the level
of the phospholipid glycerol backbone. Such localization
would allow lysine residues along one face of the helix to
extend into the aqueous phase and potentially interact with
lipid phosphates, and the nonpolar residues along the other
face of the helix to be buried in the hydrophobic phase of the
lipid alkyl chains.
Membrane-binding afﬁnity
Binding isotherms were determined by titrating spin-labeled
peptides with LUVs (see Materials and Methods) composed
of either PE/PG/CL (68:26:6 molar ratio) or POPE/POPG
(80:20 mol/mol). Representative binding curves are shown
for several CM15 analogs in Fig. 5, and molar partition
coefﬁcients are given in Table 3. All of the peptides showed
an upward curvature in their binding isotherms at relatively
low mole fractions of bound peptide, suggesting a positive
cooperativity in the early stages of membrane binding
(Spuhler et al., 1994; Han and Tamm, 2000). This was
followed by an essentially linear phase of maximal binding
afﬁnity, and ﬁnally a decrease in apparent binding afﬁnity at
higher concentrations of bound peptide due to partial
neutralization of the negative surface charge of the liposomes
by bound peptide. Binding appeared to saturate at 3–4 mol %
of the outer leaﬂet lipid concentration with POPE/POPG
bilayers (Fig. 5) and at slightly higher concentrations (4–6
mol %) with BPL liposomes, consistent with the higher
surface potential in the latter system.
Apparent partition coefﬁcients, Kp, were calculated based
on the linear regions of the binding isotherms where binding
afﬁnity is maximal (Fig. 5). Kp values were relatively similar
among the various peptides, with the exception of CM15-C4
for which binding was signiﬁcantly weaker (Table 3). Given
that PG and CL carry one and two negative charges per
molecule, respectively, membranes composed of BPL have
a very high negative surface charge density (i.e., ;38 mol
%). Consequently, it is expected that electrostatic interac-
tions will promote strong binding of CM15 analogs to BPL
liposomes. Kp values were signiﬁcantly lower for PE/PG
(80:20) LUVs than for liposomes composed of BPL, con-
ﬁrming a strong electrostatic component/membrane associ-
ation even in the presence of 100 mM KCl.
Based on apparent partition coefﬁcients it is possible to
evaluate differences in the free energies of binding for the
various peptides. Considering only those analogs labeled in
the C-terminal domain, the free energy of transfer from the
aqueous to the membrane phase, DGt, for the peptide with
the greatest binding afﬁnity (CM15-C12), was 0.4 kcal/
mol greater than that for the weakest binding peptide, CM15-
C10 (Table 3). For CM15-C4, DGt was less negative than
that of C10 by an additional 0.35 kcal/mol. Differences in
DGt between BPL liposomes and LUVs composed of POPE/
POPG (80:20) ranged from;0.4 kcal/mol for CM15-C10 to
1.4 kcal/mol for CM15-C4.
DISCUSSION
The interaction of small, basic antimicrobial peptides with
membranes is a key factor in determining their biological
FIGURE 5 Binding isotherms obtained with POPE/POPG (80:20)
vesicles for CM15 analogs spin-labeled at (D) C4, (d) C8, (3) C10, and
() C12. Xb is the molar ratio of bound peptide/accessible lipid, where
accessible lipid is one-half the total lipid concentration and Cf is the
concentration of peptide remaining free in solution. Straight lines indicate
regions of maximum slope used for calculation of Kp. All experiments were
done at room temperature in the presence of 20 mM MOPS and 100 mM
KCl at pH 7.
TABLE 3 Partition coefﬁcients for the binding of MTSL-labeled
CM15 analogs with PE/PG and bacterial polar lipid vesicles
Kp (M
1)
Labeling site POPE/POPG (8:2) BPL
C4 0.04 6 0.02 3 104 0.46 6 0.15 3 104
C8 0.39 6 0.04 3 104 1.78 6 0.35 3 104
C10 0.31 6 0.04 3 104 0.95 6 0.31 3 104
C11 0.30 6 0.03 3 104 0.83 6 0.26 3 104
C12 0.40 6 0.04 3 104 1.81 6 0.32 3 104
C14 0.33 6 0.03 3 104 1.53 6 0.33 3 104
Kp was determined from the maximum slope of binding isotherms as shown
in Fig. 5. Error estimates are based on the uncertainty in the linear
regression analysis. Replicate experiments were in good agreement with the
values shown (i.e., within the given error limits). The composition of BPL
is PE/PG/cardiolipin (68:26:6 mol %).
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activity. For many of these peptides, membrane disruption is
considered to be the primary mechanism of cell killing
(Maloy and Kari, 1995; Silvestro et al., 2000; Zasloff, 2002;
Shai, 2002). With this in mind we have investigated a series
of small, cecropin-mellitin (CM) hybrid peptides with the
goals of determining their structure and orientation upon
initial membrane binding, their localization in the lipid
bilayer, and their binding afﬁnity for bilayers having a lipid
composition similar to that of the bacterial cytoplasmic
membrane.
All of the peptides bound to liposomes composed of either
PE/PG/CL (68:26:6) or POPE/POPG (80:20) with high
afﬁnity, and with positive cooperativity at relatively low
concentrations of bound peptide. Self-promoted uptake
(Hancock and Chapple, 1999; Sawyer et al., 2003) and
sigmoidal binding curves (Hancock and Scott, 2000; Chen
et al., 2002) are a common characteristic of antimicrobial
peptides, and we have previously observed a similar positive
cooperativity in the binding isotherms of a full-length
cecropin (Mchaourab et al., 1994). This is usually taken as
an indication of peptide-peptide interaction (Spuhler et al.,
1994; Han and Tamm, 2000), although it could also reﬂect
changes in bilayer structure that enhance subsequent peptide
binding (Chen et al., 2002). We observed no evidence for
peptide aggregation in the initial stages of peptide binding (at
lipid/peptide ratios of ﬃ120:1 or greater). There was also no
obvious indication of peptide aggregation at higher concen-
trations of bound peptide. Maintaining membrane-bound
peptides in a monomeric aggregation state was important in
facilitating the mapping of secondary structure that was the
focus of this study; however, further studies are in progress
to determine if aggregation occurs in the membrane as the
concentration of bound peptide is increased.
With the exception of CM15-C4, apparent partition
coefﬁcients were similar for all of the peptides studied,
indicating that the position of the spin-label had little effect
on peptide binding as long as the attachment site was in the
relatively hydrophobic C-terminal domain. The diminished
binding afﬁnity of CM15-C4 afﬁrms that the energetics of
membrane association depends on more than just the average
physical properties of a given peptide, such as net charge or
mean residue hydrophobicity. For example, CM15-C4 and
CM15-C12 are both leucine-to-cysteine substitutions and
have identical amino acid compositions, yet differ signiﬁ-
cantly in their binding afﬁnities for both membrane systems
examined. Thus, sequence context also plays a role in the
effects of a given amino acid substitution on the membrane
interactions of these small heterogeneous peptides. This is in
agreement with the conclusions reached in comparative
studies based on antimicrobial and hemolytic activities—-
that, although general trends in the relationship between
physical properties and biological activity can be identiﬁed
for groups of peptides, the effects of a given amino acid
substitution on any individual peptide are difﬁcult to predict
(Dathe and Wieprecht, 1999; Giangaspero et al., 2001).
Our studies indicate that at low concentrations of bound
peptide, small cecropin-mellitin hybrid peptides intercalate
into the membrane just below the surface of the bilayer, and
adopt an a-helical conformation with the helix axis parallel
to the membrane surface. Peptide localization is such that
side chains along the hydrophobic face of the helix,
including those of Leu-4, Ile-10, and Leu-12, are buried in
the hydrophobic phase of the bilayer whereas the hydrophilic
residues, notably the four lysines in the N-terminal domain
and Lys-13, are within reach of the membrane-aqueous
interface with the potential for ion pairing with lipid
phosphates. Our results are consistent with formation of
a single a-helix that encompasses the full length of the
peptide. Evidence for helical structure is very strong for the
C-terminal half of the peptide, i.e., from residues 8–14,
where ﬁve of the seven sites were labeled (Fig. 4). Although
the depth for C4 mapped closely to that expected if the helix
extends through the entire length of the peptide, evidence for
helical structure in the N-terminal half of CM15 is less
rigorous given that only one of the ﬁrst seven sites was
labeled, and ﬂexibility about the glycine residue at position 9
cannot be ruled out. Nonetheless, our results are consistent
with previous CD studies indicating that CM15 forms
;100% a-helix in 16–20% HFIP (Andreu et al., 1992;
Juvvadi et al., 1996).
Previous studies using internal reﬂectance Fourier-trans-
form infrared spectroscopy (Silvestro and Axelsen, 2000),
oriented CD (Chen et al., 2001), and solid-state NMR
(Marassi et al., 1999) have all concluded that, in the initial
stages of membrane binding, full-length (35–37 residue)
cecropins adopt helical secondary structures that are aligned
parallel the bilayer surface. Similarly, based on oriented CD
studies Huang and co-workers have shown that a number of
amphipathic antimicrobial peptides are initially embedded in
the headgroup region of the bilayer, parallel to the membrane
surface (Ludtke et al., 1996; Heller et al., 1998; Huang,
2000). They have suggested that this initial interaction leads
to a thinning of the lipid bilayer that progresses with
increasing concentrations of bound peptide until a critical
threshold is reached, at which point a structural transition
occurs resulting in reorientation of membrane-bound peptide
(Huang, 2000). The localization that we have observed for
CM15 is consistent with the initial phase of this mechanism,
in that immersion of the peptide near the phospholipid
glycerol backbone would necessitate surface expansion and
a concomitant thinning of the hydrophobic phase. Whether
this leads to membrane disruption by a detergentlike
mechanism, ion-channel formation, or translocation across
the membrane and interaction with cytoplasmic targets for
this particular group of minimized antimicrobial peptides,
remains to be determined.
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